ClinicalTrials.gg
Sign In

Drug

Fosrolapitant clinical trials

studies test it
3
open now
2
in phase 3
0
first study started
2026

Keep track of what changes. Save the fosrolapitant studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Combined with it in one product

Fosrolapitant and Palonosetron; Dexamethasone; Olanzapine
1
Fosrolapitant and Palonosetron; Dexamethasone
1
Fosrolapitant and Palonosetron for injection
1
Fosrolapitant and Palonosetron Hydrochloride for Injection
1

By phase

A phase 1/2 study counts in both.

Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Nausea
1
Vomiting
1

Who runs them

Industry 0 · Other 3

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Peking University Cancer Hospital & Institute (1) · Tianjin Medical University Cancer Institute and Hospital (1)

Often tested with

Tested in the same studies.

Palonosetron (3) · Dexamethasone (1) · Olanzapine (1)

Studies

Open first, then newest update. How each study uses fosrolapitant is read from its arms, and is right about nine times in ten.

Testing it · 3

Given in every arm · 1 — fosrolapitant is usual care beside what is tested

Codes

What other systems call fosrolapitant · ClinicalTrials.gg INT017246

  • UNII (FDA) M5QGY92X8BFOSROLAPITANTConfirmed FDA, Wikidata
  • Wikidata Q137675358fosrolapitantConfirmed FDA, Wikidata
  • NCI Thesaurus C211673FosrolapitantOne source FDA
  • DrugBank DB21723One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.